Hinge Health, Inc. Class A (HNGE)
NYSE:HNGE
Want to see HNGE full AI Analyst Report?
HNGE Stock Chart & Stats
$43.32
-$1.41(-3.71%)
At close: 4:00 PM EDT
$43.32
-$1.41(-3.71%)
Day’s Range― - ―
52-Week Range$30.08 - $62.18
Previous Close$36.79
Volume525.07K
Average Volume (3M)1.31M
Market Cap
$4.24B
Enterprise Value$4.05B
Total Cash (Recent Filing)$317.31M
Total Debt (Recent Filing)$6.97M
Price to Earnings (P/E)21.6
Beta2.00
Next Earnings
Aug 04, 2026EPS Estimate
0.6Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-6.58
Shares Outstanding54,655,926
10 Day Avg. Volume2,513,637
30 Day Avg. Volume1,312,901
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)9.72
Price to Sales (P/S)6.26
P/FCF Ratio21.54
Enterprise Value/Market Cap0.96
Enterprise Value/Revenue6.27
Enterprise Value/Gross Profit7.76
Enterprise Value/Ebitda-7.81
Forecast
1Y Price Target
$68.15Price Target Upside57.33% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering13
EPS Forecast (FY)2.46
Revenue Forecast (FY)$797.14M
Bulls Say, Bears Say
Bulls Say
AI-driven EfficiencyAI-powered tools and automated communications are enabling Hinge Health to serve more members without expanding care team size, supporting margin expansion through lower care delivery costs.
Member GrowthStrong app download trends and increasing average sessions per member indicate continued member growth and deeper user engagement for Hinge Health.
Strategic PartnershipsStrong partnerships with major health plans and PBMs provide Hinge Health a meaningful go-to-market advantage, helping secure high client win rates and contract growth.
Bears Say
Customer Mix RiskA higher proportion of small- and medium-sized customers could make it harder for Hinge Health to sustain yield improvements compared with a larger-enterprise customer base.
Market Sentiment RiskBroad software-sector concerns about AI disruption have pressured Hinge Health shares and amplified investor skepticism despite operational momentum.
Pricing Model UncertaintyUncertainty around the transition to a usage-based pricing model and stable average selling prices could limit revenue per member and constrain upside from pricing improvements.
Hinge Health, Inc. Class A News
HNGE FAQ
What was Hinge Health, Inc. Class A’s price range in the past 12 months?
Hinge Health, Inc. Class A lowest stock price was $30.08 and its highest was $62.18 in the past 12 months.
What is Hinge Health, Inc. Class A’s market cap?
Hinge Health, Inc. Class A’s market cap is $4.24B.
When is Hinge Health, Inc. Class A’s upcoming earnings report date?
Hinge Health, Inc. Class A’s upcoming earnings report date is Aug 04, 2026 which is in 75 days.
How were Hinge Health, Inc. Class A’s earnings last quarter?
Hinge Health, Inc. Class A released its earnings results on May 05, 2026. The company reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.397 by $0.053.
Is Hinge Health, Inc. Class A overvalued?
According to Wall Street analysts Hinge Health, Inc. Class A’s price is currently Undervalued.
Does Hinge Health, Inc. Class A pay dividends?
Hinge Health, Inc. Class A does not currently pay dividends.
What is Hinge Health, Inc. Class A’s EPS estimate?
Hinge Health, Inc. Class A’s EPS estimate is 0.6.
How many shares outstanding does Hinge Health, Inc. Class A have?
Hinge Health, Inc. Class A has 54,655,926 shares outstanding.
What happened to Hinge Health, Inc. Class A’s price movement after its last earnings report?
Hinge Health, Inc. Class A reported an EPS of $0.45 in its last earnings report, beating expectations of $0.397. Following the earnings report the stock price went up 10.231%.
Which hedge fund is a major shareholder of Hinge Health, Inc. Class A?
Currently, no hedge funds are holding shares in HNGE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Hinge Health, Inc. Class A Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$68.15 (57.33% Upside)
$68.15 (57.33% Upside)
Blogger Sentiment
Bullish
HNGE Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 3.3M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▲ 1.5%
Last 30 Days ▼ 0.5%
Last 30 Days ▼ 0.5%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Fundamentals
Return on Equity
-138.70%
Trailing 12-Months
Asset Growth
2.28%
Trailing 12-Months
Company Description
Hinge Health, Inc. Class A
Hinge Health, Inc. develops health care software for joint and muscle health. The company designs its platform to address a musculoskeletal care, acute injury, chronic pain, and post-surgical rehabilitation. It also provides various administrative and operations support services. The company was founded in 2012 and is headquartered in San Francisco, California.
HNGE Company Deck
HNGE Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong operational and financial momentum: a material revenue beat, double-digit growth in billings, substantial margin expansion, strong free cash flow, raised full-year guidance, rapid client uptake of the new migraine program following FDA clearance, and expanding commercial traction (including SMB and Hinge Select). Headwinds and risks include limited near-term revenue from migraine (meaningful benefit expected in 2027), concentration of new bookings in the back half of the year, continued device-related cost pressures as Enso distribution scales, and a deliberate decision to forgo the CMS ACCESS program. Overall, the positives (robust growth, margin expansion, guidance raise, product and commercial wins) substantially outweigh the near-term lowlights and risks.View all HNGE earnings summariesHNGE Stock 12 Month Forecast
Average Price Target
$68.15
▲(57.33% Upside)
Technical Analysis
Ownership Overview
8.61% Insiders
13.98% Mutual Funds
67.16% Other Institutional Investors
5.03% Public Companies and
Individual Investors